A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial

Merete Lund Hetland, Espen A Haavardsholm, Anna Rudin, Dan Nordström, Mike Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Kim Hørslev-Petersen, Till Uhlig, Gerdur Grondal, Mikkel Østergaard, Marte Heiberg, Jos Twisk, Kristina Lend, Simon Krabbe, Joakim Lindqvist, Anna-Karin Ekwall, Kathrine Lederballe Grøn, Meliha Kapetanovic, Francesca FaustiniRiitta Tuompo, Tove Lorenzen, Giovanni Cagnotto, Eva Baecklund, Oliver Hendricks, Daisy Vedder, Tuulikki Sokka-isler, Tomas Husmark, Maud-Kristine Aga Ljoså, Eli Brodin, Torkell Ellingsen, Annika Söderbergh, Milad Rizk, Åsa Reckner, Line Uhrenholt, Per Larsson, Soeren Just, David Stevens, Trine Laurberg, Gunnstein Bakland, Inge Christoffer Olsen, Ronald van Vollenhoven, NORD-STAR Study Group

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberL09
JournalArthritis & Rheumatology
Volume71
Issue numberSuppl. 10
Pages (from-to)5237-5240
ISSN2326-5205
Publication statusPublished - 2019
Event2019 ACR/ARP Annual Meeting - Atlanta, United States
Duration: 8 Nov 201913 Nov 2019

Conference

Conference2019 ACR/ARP Annual Meeting
Country/TerritoryUnited States
CityAtlanta
Period08/11/201913/11/2019

Cite this